Rare Genetic Disorder Named After Abu Dhabi Specialist in Landmark UAE Breakthrough
El-Hattab-Schmidts syndrome, a newly recognised rare genetic neurodevelopmental disorder linked to PPP1R21…
London Biotechnology Show 2026 Names MedEdge MEA as Media Partner
The London Biotechnology Show 2026 will take place on 9–10 June at…
BD Unveils Connected Care Strategy to Advance Predictive, Data-Driven Healthcare
BD (Becton, Dickinson and Company) has unveiled its Connected Care strategy, an…
Future X Stage Opens at WHX Dubai 2026
Four-day programme showcases bold disruptors and scalable solutions shaping the next 50…
Global Leaders Align on Prevention and AI at WHX
Invitation-only WHX Leaders summit convenes policymakers and healthcare executives to shape the…
Bayer and Vanderbilt University Medical Center Launch Five-Year Research Collaboration in Cardiovascular and Kidney Diseases
Bayer and Vanderbilt University Medical Center have entered a five-year strategic partnership…
Abu Dhabi Biobank and AstraZeneca Partner to Advance Precision Medicine and Translational Research
Abu Dhabi Biobank has partnered with AstraZeneca to leverage genomic research and…
PureHealth Forms Health Longevity Advisory Board to Advance Ageing Science in the Middle East
PureHealth establishes a global Health Longevity Advisory Board to advance healthy ageing,…
Abu Dhabi Opens Applications for 2026 Healthcare Research and Innovation Fund
Abu Dhabi has opened applications for its 2026 Healthcare Research and Innovation…
The Emirates Drug Foundation approves gene therapy for gene replacement in a new age group of spinal muscular atrophy patients.
The Emirates Drug Authority (EDA) has announced the approval of Itvisma, a…
